CTOs on the Move

Cambell County Memorial Hospital

www.ccmh.net

 
Campbell County Hospital District, doing business as Campbell County Memorial Hospital, operates as a community hospital that provides healthcare services serving patients and residents in Gillette. The company offers emergency medical services, behavioral health services, cancer care, outpatient services, emergency care, home medical care, occupational health services, first aid and CPR services, OB GYN services, audiology, internal medicine, infectious disease care, neurology and pain care, geriatric medicine, nephrology, pulmonary and sleep medicine, urology, home care services, laboratory services, nutritional care, radiology, rehabilitation services, hospice care, ICU services, orthopedics and spine care, surgery, maternal child care, powder river surgery, nursing, and ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.ccmh.net
  • 501 S Burma Ave
    Gillette, WY USA 82716-3426
  • Phone: 307.688.1000

Executives

Name Title Contact Details

Similar Companies

Lite Source Inc

Lite Source Inc is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Health

Health & Wellness Services Community Health Centers of the Rutland Region has Primary Care Offices offering a full range of services including preventative health care (annual physicals, work physicals, school, camp and sports physicals), women’s ...

alicare

alicare is a West Harrison, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Calox

Calox is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.